pharma news today obesity drugs glp-1 september 2025 medications like Ozempic, Wegovy and Mounjaro are changing diabetes and weight management, but they aren't recommended during pregnancy or while nursing. The current recommendation is to stop before conception and discuss GLP-1 Pharmacy Pricing Update (Dec

Furthermore, the data from a phase II study in participants with obesity and MASH presented at the American Diabetes Association showed those on survodutide achieved 18.7% mean weight loss after 46 weeks compared to the placebo group

Ren, X., Zhang, H., Geng, N., Xing, L., Zhao, Y., Wang, F., & Chen, J

Strongest glycemic evidence SURPASS-2 is the most cited head-to-head against semaglutide for HbA1c reduction in type 2 diabetes

GLP-1 RAs are recommended as the first injectable agent (over insulin) in most patients with T2D when the glucose-lowering efficacy of an injectable agent is desired

A recent study pointed out that GLP-1 can reduce liver fat synthesis